Revolution Medicines, Inc.
Anthony Mancini (See Remarks) sells RVMD shares
About this filing
Revolution Medicines, Inc. (RVMD) filed Form 4 (insider transaction) with the SEC on Sep 28, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Anthony Mancini · See Remarks
Rule 10b5-1 plan · adopted Jun 11, 2026
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | S · open-market saleFootnotes F1 | −587 | $200.00 | $117,400.00 | 39,765 | Direct |
| Sep 25, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +3,121 | $33.62 | $104,928.02 | 42,886 | Direct |
| Sep 25, 2026 | S · open-market saleFootnotes F1, F2 | −3,121 | $200.54 | $625,885.34 | 39,765 | Direct |
| Sep 25, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1, F3 | −3,121 | $0.00 | $0.00 | 93,625 | Direct |
Footnotes
- F1 Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026.
- F2 Includes 39,575 restricted stock units.
- F3 Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from April 1, 2025 (the "Vesting Commencement Date") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
Remarks: Chief Global Commercialization Officer
More RVMD filings
- SC 13G
Filed Oct 30, 2026
- 4
Filed Oct 28, 2026
- 8-K
Filed Oct 13, 2026
- 4
Filed Oct 1, 2026
- 4
Filed Sep 29, 2026
- 144
Filed Sep 29, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.